https://aldosteroneyang.com 2026-04-19T10:53:00.636Z always 1.0 https://aldosteroneyang.com/ucits-factor-etf-analysis-as-of-202602 2026-04-17T16:45:08.761Z daily 0.8 https://aldosteroneyang.com/ucits-factor-etf-analysis-as-of-202601-1 2026-03-17T16:45:05.420Z daily 0.8 https://aldosteroneyang.com/ucits-factor-etf-analysis-as-of-202512 2026-02-17T16:44:57.620Z daily 0.8 https://aldosteroneyang.com/ucits-factor-etf-analysis-as-of-202511 2026-01-17T16:44:54.341Z daily 0.8 https://aldosteroneyang.com/ucits-factor-etf-analysis-as-of-202510 2025-12-17T16:45:06.860Z daily 0.8 https://aldosteroneyang.com/ucits-factor-etf-analysis-as-of-202509 2025-11-17T16:44:55.463Z daily 0.8 https://aldosteroneyang.com/podcast-episode-383-ama-10-dollar-cost-averaging-amp-mutual-funds-vs-etfs-rational-reminder 2025-11-15T16:49:24.191Z daily 0.8 https://aldosteroneyang.com/podcast-episode-382-ted-cadsby-the-power-of-index-funds-and-being-human-rational-reminder 2025-11-08T16:49:24.535Z daily 0.8 https://aldosteroneyang.com/podcast-episode-381-investing-101-rational-reminder 2025-11-01T16:49:29.111Z daily 0.8 https://aldosteroneyang.com/podcast-episode-380-john-y-campbell-fixing-personal-finance-rational-reminder 2025-10-25T16:49:57.493Z daily 0.8 https://aldosteroneyang.com/body-composition-radiomics-combined-with-machine-learning-for-early-recurrence-prediction-in-intrahepatic-cholangiocarcinoma-following-curative-surgery-a-multi-center-study 2025-10-24T16:48:10.211Z daily 0.8 https://aldosteroneyang.com/podcast-episode-379-ama-9-covered-call-etfs-currency-hedging-and-bond-misconceptions-rational-reminder 2025-10-18T16:49:34.532Z daily 0.8 https://aldosteroneyang.com/ucits-factor-etf-analysis-as-of-202508 2025-10-17T16:45:01.207Z daily 0.8 https://aldosteroneyang.com/podcast-episode-378-mark-higgins-learning-from-market-history-rational-reminder 2025-10-11T16:49:33.162Z daily 0.8 https://aldosteroneyang.com/podcast-episode-377-investing-in-your-healthnbsp-rational-reminder 2025-10-04T16:49:42.332Z daily 0.8 https://aldosteroneyang.com/podcast-episode-376-nick-maggiulli-climbing-the-wealth-ladder-rational-reminder 2025-09-27T16:49:44.822Z daily 0.8 https://aldosteroneyang.com/podcast-episode-375-covered-calls-a-devils-bargain-rational-reminder 2025-09-20T16:49:22.876Z daily 0.8 https://aldosteroneyang.com/ucits-factor-etf-analysis-as-of-202507 2025-09-17T16:44:59.721Z daily 0.8 https://aldosteroneyang.com/podcast-episode-374-david-c-brown-the-underperformance-of-target-date-funds-rational-reminder 2025-09-13T16:49:23.369Z daily 0.8 https://aldosteroneyang.com/enhancing-interpretability-of-ai-with-radiomics-based-deep-neural-network-proof-of-concept-in-the-classification-of-parkinsonian-syndromes-with-18f-fdg-pet-imaging 2025-09-11T16:47:51.485Z daily 0.8 https://aldosteroneyang.com/podcast-episode-373-asset-allocation-in-practice-rational-reminder 2025-09-06T16:49:21.540Z daily 0.8 https://aldosteroneyang.com/artificial-intelligence-assisted-assessment-of-metabolic-response-to-tebentafusp-in-metastatic-uveal-melanoma-a-long-axial-field-of-view-18f-fdg-pet-ct-study 2025-09-06T16:47:27.801Z daily 0.8 https://aldosteroneyang.com/podcast-episode-372-elie-hassenfeld-approximately-optimal-philanthropy-rational-reminder 2025-08-30T16:49:24.836Z daily 0.8 https://aldosteroneyang.com/podcast-episode-371-banks-sell-products-not-advice-rational-reminder 2025-08-23T16:49:25.140Z daily 0.8 https://aldosteroneyang.com/ucits-factor-etf-analysis-as-of-202506 2025-08-17T16:45:03.073Z daily 0.8 https://aldosteroneyang.com/podcast-episode-370-dave-chilton-the-wealthy-barber-timeless-financial-advice-rational-reminder 2025-08-16T16:49:36.852Z daily 0.8 https://aldosteroneyang.com/podcast-episode-369-the-most-important-quotes-in-investingnbsp-rational-reminder 2025-08-09T16:49:28.544Z daily 0.8 https://aldosteroneyang.com/podcast-episode-368-jim-rowley-amp-andy-maack-implementing-index-funds-at-vanguard-rational-reminder 2025-08-02T16:49:25.877Z daily 0.8 https://aldosteroneyang.com/podcast-episode-367-ama-8-insurance-needs-analysis-with-louai-bibi-rational-reminder 2025-07-26T16:49:17.745Z daily 0.8 https://aldosteroneyang.com/podcast-episode-366-avoiding-investment-scams-rational-reminder 2025-07-20T16:51:53.419Z daily 0.8 https://aldosteroneyang.com/ucits-factor-etf-analysis-as-of-202505 2025-07-17T16:45:00.107Z daily 0.8 https://aldosteroneyang.com/podcast-episode-365-rob-carricks-eight-lessons-learned-in-27-years-of-covering-personal-finance-rational-reminder 2025-07-12T16:49:26.626Z daily 0.8 https://aldosteroneyang.com/podcast-episode-364-martijn-cremers-is-the-conventional-wisdom-on-active-management-wrong-rational-reminder 2025-07-05T16:49:26.501Z daily 0.8 https://aldosteroneyang.com/podcast-episode-363-the-underappreciated-risk-of-individual-stocks-rational-reminder 2025-06-28T16:49:19.793Z daily 0.8 https://aldosteroneyang.com/podcast-episode-362-ama-7-rational-reminder 2025-06-21T16:49:28.929Z daily 0.8 https://aldosteroneyang.com/ucits-factor-etf-analysis-as-of-202504 2025-06-17T16:44:58.705Z daily 0.8 https://aldosteroneyang.com/podcast-episode-361-alex-edmans-finding-the-truth-in-economics-finance-and-life-rational-reminder 2025-06-16T01:53:38.012Z daily 0.8 https://aldosteroneyang.com/podcast-episode-360-gerard-oreilly-the-components-of-net-returns-rational-reminder 2025-06-07T16:49:36.628Z daily 0.8 https://aldosteroneyang.com/podcast-episode-359-the-most-controversial-topics-in-personal-finance-rational-reminder 2025-05-31T16:49:30.884Z daily 0.8 https://aldosteroneyang.com/podcast-episode-358-eli-beracha-an-academic-perspective-on-renting-vs-owning-a-home-rational-reminder 2025-05-24T16:49:23.742Z daily 0.8 https://aldosteroneyang.com/podcast-episode-357-ama-6-rational-reminder 2025-05-17T16:49:36.430Z daily 0.8 https://aldosteroneyang.com/ucits-factor-etf-analysis-as-of-202503 2025-05-17T16:44:59.399Z daily 0.8 https://aldosteroneyang.com/measurement-of-cyclosporin-induced-changes-in-p-glycoprotein-function-at-the-human-blood-brain-barrier-using-18f-mc225-and-pet 2025-05-11T04:42:06.206Z daily 0.8 https://aldosteroneyang.com/cost-utility-analysis-of-177lu-psma-617-radioligand-therapy-in-second-line-and-third-line-treatment-for-metastatic-castration-resistant-prostate-cancer-mcrpc-in-germany 2025-05-11T04:22:57.864Z daily 0.8 https://aldosteroneyang.com/podcast-episode-356-abby-davisson-how-to-make-decisions-about-money-and-love-rational-reminder 2025-05-11T04:05:12.452Z daily 0.8 https://aldosteroneyang.com/podcast-episode-355-do-index-funds-incur-adverse-selection-costs-rational-reminder 2025-05-03T16:49:25.968Z daily 0.8 https://aldosteroneyang.com/dicom-header-editing-between-possibilities-and-regulatory-bounds-40-years-of-dicom-standard 2025-05-01T16:47:27.001Z daily 0.8 https://aldosteroneyang.com/article-review-dicom-header-editing-between-possibilities-and-regulatory-bounds-40-years-of-dicom-standard 2025-05-01T16:47:26.609Z daily 0.8 https://aldosteroneyang.com/psma-pet-ct-in-biochemical-recurrence-of-prostate-cancer-with-psa-levels-0-2-ng-ml-a-german-multicenter-analysis-of-conventional-psma-tracers-including-68ga-ga-psma-11-68ga-ga-psma-i-amp-t-and-18f-psma-1007 2025-04-30T16:47:38.684Z daily 0.8 https://aldosteroneyang.com/article-review-psma-pet-ct-in-biochemical-recurrence-of-prostate-cancer-with-psa-levels-0-2-ng-ml-a-german-multicenter-analysis-of-conventional-psma-tracers-including-68ga-ga-psma-11-68ga-ga-psma-i-amp-t-and-18f-psma-1007 2025-04-30T16:47:38.036Z daily 0.8 https://aldosteroneyang.com/efficacy-of-combined-targeted-radionuclide-therapy-and-immune-checkpoint-inhibition-in-animal-tumour-models-a-systematic-review-and-meta-analysis-of-the-literature 2025-04-26T16:47:44.002Z daily 0.8 https://aldosteroneyang.com/article-review-efficacy-of-combined-targeted-radionuclide-therapy-and-immune-checkpoint-inhibition-in-animal-tumour-models-a-systematic-review-and-meta-analysis-of-the-literature 2025-04-26T16:47:43.450Z daily 0.8 https://aldosteroneyang.com/fast-4d-pet-parametric-imaging-computation-at-the-whole-field-of-view-level-reliability-under-simulated-conditions-of-pet-kinetix-a-dedicated-software-solution 2025-04-21T16:48:48.050Z daily 0.8 https://aldosteroneyang.com/article-review-fast-4d-pet-parametric-imaging-computation-at-the-whole-field-of-view-level-reliability-under-simulated-conditions-of-pet-kinetix-a-dedicated-software-solution 2025-04-21T16:48:47.389Z daily 0.8 https://aldosteroneyang.com/podcast-episode-353-ama-5-rational-reminder 2025-04-20T01:02:13.538Z daily 0.8 https://aldosteroneyang.com/dark-seasons-enhance-brain-and-brown-adipose-tissue-interactions-related-to-mu-opioid-receptor-signaling 2025-04-17T16:47:41.356Z daily 0.8 https://aldosteroneyang.com/article-review-dark-seasons-enhance-brain-and-brown-adipose-tissue-interactions-related-to-mu-opioid-receptor-signaling 2025-04-17T16:47:40.785Z daily 0.8 https://aldosteroneyang.com/ucits-factor-etf-analysis-as-of-202502 2025-04-17T16:44:57.034Z daily 0.8 https://aldosteroneyang.com/podcast-episode-352-jessica-moorhouse-everything-but-money-rational-reminder 2025-04-12T16:49:43.160Z daily 0.8 https://aldosteroneyang.com/forearm-metastasis-as-solitary-manifestation-of-recurrent-prostate-cancer-a-challenge-for-standard-psma-pet-imaging-protocol 2025-04-11T16:47:24.493Z daily 0.8 https://aldosteroneyang.com/article-review-forearm-metastasis-as-solitary-manifestation-of-recurrent-prostate-cancer-a-challenge-for-standard-psma-pet-imaging-protocol 2025-04-11T16:47:23.951Z daily 0.8 https://aldosteroneyang.com/cancer-control-outcomes-of-radium-223-pretreated-lutetium-177-psma-radioligand-vs-radium-223-na-ve-mcrpc-patients 2025-04-07T16:47:29.566Z daily 0.8 https://aldosteroneyang.com/article-review-cancer-control-outcomes-of-radium-223-pretreated-lutetium-177-psma-radioligand-vs-radium-223-na-ve-mcrpc-patients 2025-04-07T16:47:28.942Z daily 0.8 https://aldosteroneyang.com/podcast-episode-351-dfa-vs-vanguard-rational-reminder-1 2025-04-05T17:49:29.472Z daily 0.8 https://aldosteroneyang.com/podcast-episode-351-dfa-vs-vanguard-rational-reminder 2025-04-05T17:33:41.928Z daily 0.8 https://aldosteroneyang.com/leveraging-machine-learning-with-dynamic-18f-fdg-pet-ct-integrating-metabolic-and-flow-features-for-lung-cancer-differential-diagnosis 2025-04-04T16:49:44.453Z daily 0.8 https://aldosteroneyang.com/article-review-leveraging-machine-learning-with-dynamic-18f-fdg-pet-ct-integrating-metabolic-and-flow-features-for-lung-cancer-differential-diagnosis 2025-04-04T16:49:43.843Z daily 0.8 https://aldosteroneyang.com/68ga-ga-fapi-04-pet-ct-in-a-patient-with-endometriosis-a-potential-game-changer 2025-04-04T16:47:29.763Z daily 0.8 https://aldosteroneyang.com/article-review-68ga-ga-fapi-04-pet-ct-in-a-patient-with-endometriosis-a-potential-game-changer 2025-04-04T16:47:29.054Z daily 0.8 https://aldosteroneyang.com/vancomycin-based-tracers-guiding-in-situ-visualization-of-bacteria-on-osteosynthesis-devices-and-surgical-debridement 2025-04-02T16:51:48.493Z daily 0.8 https://aldosteroneyang.com/article-review-vancomycin-based-tracers-guiding-in-situ-visualization-of-bacteria-on-osteosynthesis-devices-and-surgical-debridement 2025-04-02T16:51:48.013Z daily 0.8 https://aldosteroneyang.com/optimizing-antibody-pet-imaging-a-comparative-preclinical-analysis-of-nanobody-and-minibody-like-pet-tracers 2025-03-31T16:47:52.229Z daily 0.8 https://aldosteroneyang.com/article-review-optimizing-antibody-pet-imaging-a-comparative-preclinical-analysis-of-nanobody-and-minibody-like-pet-tracers 2025-03-31T16:47:51.493Z daily 0.8 https://aldosteroneyang.com/podcast-episode-350-scott-cederburg-a-critical-assessment-of-lifecycle-investment-advice-rational-reminder 2025-03-29T17:32:13.087Z daily 0.8 https://aldosteroneyang.com/article-review-estimation-of-technetium-99m-mag3-plasma-clearance-in-adults-from-one-or-two-blood-samples 2025-03-28T17:04:24.858Z daily 0.8 https://aldosteroneyang.com/beyond-similarities-overall-survival-and-prognostic-insights-from-lu-lu-dotatoc-therapy-in-neuroendocrine-tumors 2025-03-28T16:48:16.707Z daily 0.8 https://aldosteroneyang.com/article-review-beyond-similarities-overall-survival-and-prognostic-insights-from-lu-lu-dotatoc-therapy-in-neuroendocrine-tumors 2025-03-28T16:48:16.216Z daily 0.8 https://aldosteroneyang.com/capacity-for-brain-amyloid-pet-in-germany-results-from-the-1st-survey-on-nuclear-brain-imaging-in-germany 2025-03-27T16:47:22.882Z daily 0.8 https://aldosteroneyang.com/article-review-capacity-for-brain-amyloid-pet-in-germany-results-from-the-1st-survey-on-nuclear-brain-imaging-in-germany 2025-03-27T16:47:22.155Z daily 0.8 https://aldosteroneyang.com/report-generator-myocardial-perfusion-imaging 2025-03-27T03:35:51.557Z daily 0.8 https://aldosteroneyang.com/chinese-management-guidelines-for-radioactive-iodine-refractory-differentiated-thyroid-cancer-2025-edition 2025-03-25T16:47:13.029Z daily 0.8 https://aldosteroneyang.com/article-review-chinese-management-guidelines-for-radioactive-iodine-refractory-differentiated-thyroid-cancer-2025-edition 2025-03-25T16:47:12.341Z daily 0.8 https://aldosteroneyang.com/podcast-episode-349-ama-4-rational-reminder 2025-03-23T03:26:58.652Z daily 0.8 https://aldosteroneyang.com/new-compartment-model-for-hepatic-blood-flow-quantification-in-humans-from-15o-water-pet-images 2025-03-21T16:49:16.561Z daily 0.8 https://aldosteroneyang.com/article-review-new-compartment-model-for-hepatic-blood-flow-quantification-in-humans-from-15o-water-pet-images 2025-03-21T16:49:16.175Z daily 0.8 https://aldosteroneyang.com/diagnostic-accuracy-in-nsclc-lymph-node-staging-with-total-body-and-conventional-pet-ct 2025-03-21T16:48:15.720Z daily 0.8 https://aldosteroneyang.com/article-review-diagnostic-accuracy-in-nsclc-lymph-node-staging-with-total-body-and-conventional-pet-ct 2025-03-21T16:48:15.310Z daily 0.8 https://aldosteroneyang.com/prognostic-value-of-18f-fdg-and-psma-pet-in-patients-evaluated-for-177lu-lu-psma-therapy-of-mcrpc 2025-03-21T16:47:26.347Z daily 0.8 https://aldosteroneyang.com/article-review-prognostic-value-of-18f-fdg-and-psma-pet-in-patients-evaluated-for-177lu-lu-psma-therapy-of-mcrpc 2025-03-21T16:47:25.797Z daily 0.8 https://aldosteroneyang.com/3d-image-viewer-reconstruction-and-synchronization-mechanism 2025-03-20T02:11:08.574Z daily 0.8 https://aldosteroneyang.com/ucits-factor-etf-analysis-as-of-202501 2025-03-19T00:19:25.814Z daily 0.8 https://aldosteroneyang.com/exploring-the-origins-of-frequent-tau-pet-signal-in-vermal-and-adjacent-regions 2025-03-18T16:49:04.283Z daily 0.8 https://aldosteroneyang.com/article-review-exploring-the-origins-of-frequent-tau-pet-signal-in-vermal-and-adjacent-regions 2025-03-18T16:49:03.916Z daily 0.8 https://aldosteroneyang.com/podcast-episode-348-andrew-barclay-statcan-measuring-inflation-rational-reminder 2025-03-15T16:49:08.403Z daily 0.8 https://aldosteroneyang.com/131i-spect-ct-provides-prognostic-information-in-patients-with-differentiated-thyroid-cancer 2025-03-15T16:47:18.012Z daily 0.8 https://aldosteroneyang.com/article-review-131i-spect-ct-provides-prognostic-information-in-patients-with-differentiated-thyroid-cancer 2025-03-15T16:47:17.437Z daily 0.8 https://aldosteroneyang.com/myocardial-blood-flow-reference-values-for-13n-ammonia-pet-myocardial-perfusion-imaging-in-patients-without-flow-limiting-coronary-artery-disease 2025-03-14T16:47:44.872Z daily 0.8 https://aldosteroneyang.com/article-review-myocardial-blood-flow-reference-values-for-13n-ammonia-pet-myocardial-perfusion-imaging-in-patients-without-flow-limiting-coronary-artery-disease 2025-03-14T16:47:44.398Z daily 0.8 https://aldosteroneyang.com/68ga-trivehexin-pet-ct-uptake-in-malignant-and-fibrotic-lung-tissue-refining-diagnostic-applications 2025-03-14T16:47:08.961Z daily 0.8 https://aldosteroneyang.com/article-review-68ga-trivehexin-pet-ct-uptake-in-malignant-and-fibrotic-lung-tissue-refining-diagnostic-applications 2025-03-14T16:47:08.418Z daily 0.8 https://aldosteroneyang.com/archive 2026-04-19T10:53:00.636Z daily 0.5 https://aldosteroneyang.com/recommendations 2026-04-19T10:53:00.636Z weekly 0.4